MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1141 to 1160 of 166,322 approvalsPage 58 of 8317

Loxoprofen Sodium Cataplasms

Approval Number: 国药准字H20253634
Registration: Mar 18, 2025

Rivaroxaban Tablets

Approval Number: 国药准字H20253672
Registration: Mar 18, 2025

龙胆泻肝丸

Approval Number: 国药准字Z37021258
Registration: Mar 18, 2025

Nitroglycerin sublingual tablets

Approval Number: 国药准字H20253630
Registration: Mar 18, 2025

Pipemidic Acid Tablets

Approval Number: 国药准字H37021777
Registration: Mar 14, 2025

Sildenafil Citrate Tablets

Approval Number: 国药准字H20258031
Registration: Mar 14, 2025

Diprophylline Injection

Approval Number: 国药准字H20258029
Registration: Mar 13, 2025

Naloxone Hydrochloride Injection

Approval Number: 国药准字H20258030
Registration: Mar 13, 2025

Tetanus Antitoxin

Approval Number: 国药准字S20258003
Registration: Mar 13, 2025

Nitroglycerin Injection

Approval Number: 国药准字H20253571
Registration: Mar 11, 2025

Teprotumumab N01 Injection

Approval Number: 国药准字S20250013
Registration: Mar 11, 2025

Levosalbutamol Hydrochloride Nebuliser Solution

Approval Number: 国药准字H20253617
Registration: Mar 11, 2025

Epinephrine Hydrochloride Injection

Approval Number: 国药准字H20253602
Registration: Mar 11, 2025

Nitroglycerin Injection

Approval Number: 国药准字H20253572
Registration: Mar 11, 2025

Ambroxol Hydrochloride Oral Solution

Approval Number: 国药准字HJ20250024
Registration: Mar 11, 2025

Potassium Chloride Oral Solution

Approval Number: 国药准字H20253594
Registration: Mar 11, 2025

Diprophylline Injection

Approval Number: 国药准字H20253573
Registration: Mar 11, 2025

Epinephrine Hydrochloride Injection

Approval Number: 国药准字H20253598
Registration: Mar 11, 2025

Diprophylline Injection

Approval Number: 国药准字H20253581
Registration: Mar 11, 2025

Enzalutamide Soft Capsules

Approval Number: 国药准字H20253584
Registration: Mar 11, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.